naloxone update; norway. clausen... · naloxone update; norway thomas clausen professor (dr. med)...

12
Naloxone update; Norway Thomas Clausen Professor (Dr. med) [email protected] 29. September 2016

Upload: truongtu

Post on 23-Apr-2019

229 views

Category:

Documents


0 download

TRANSCRIPT

Naloxone update; Norway

Thomas Clausen Professor (Dr. med)

[email protected]

29. September 2016

Norwegian project

Part of National overdose strategy (2014-2017) A pilot project starting in June 2014

– Oslo and Bergen

Nasal naloxone; with «interim device»

Current status; 31.08.16; extended to 5 new cities, plans for further

expansions Still using «interim device» Rapid distribution via existing low-threshold facilities Expanding to distribution into formal treatment pops.

Nasal naloxon

5 dosages of 0,4mg Nalokson

Distribution rates per pop. July 2014- August 2016

0.00

100.00

200.00

300.00

400.00

500.00

600.00

July

Au

g

Sep

t

Oct

No

v

Dec Jan

Feb

Mar

Ap

r

May Jun

July

Au

g

Sep

t

Oct

No

v

Dec Jan

Feb

Mar

Ap

r

May Jun

July

Au

g

Oslo total rate

Bergen total rate

2054 sprays by 2015 1066 by 2016 August 31st 3100 sprays in total 50% refills in 2016

Feedback and experiences

Empowering interaction for staff and users

Well received

Many reports of naloxone saves!

Important with dedicated local staff

Some concerns from staff over risk of re-overdosing, not calling the ambulance, or refusing further treatment

Stepwise scaling up

New target groups From low-threshold outside of treatment

Formal treatment

Prison release

Etc

New cities Initial 2

Current 7

Planned for 12-15 in total by next six months

Overdose deaths Weekday variation in Oslo and Bergen

Bergen (Jan. 1, 2012- Dec. 31, 2013) N=463

Oslo (Jan. 1, 2014- Dec. 31, 2015) N=1054

Overdose deaths Monthly variation in Oslo and Bergen

Oslo (Jan. 1, 2014- Dec. 31, 2015) N=1054

Bergen (Jan. 1, 2012- Dec. 31, 2013) N=463

Naloxone dosing

We believe it works!

Supporting expansion

Still awaiting overdose mortality numbers for 2015

Still awaiting formally approved and market approved nasal device

Success factors

Part of national overdose prevention strategy

Governmental funding

Waiver of need for individual prescription

Nasal spray device

Involvement of user groups and key stake-holders

Collaboration with and distribution via existing public health infrastructure

www.stoppoverdose.no